Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes Mellitus
2024

LEAP2 Hormone Changes After Diet and Endobarrier in Obesity and Diabetes

Sample size: 67 publication 10 minutes Evidence: moderate

Author Information

Author(s): Emini Mimoza, Bhargava Raghav, Aldhwayan Madhawi, Chhina Navpreet, Rodriguez Flores Marcela, Aldubaikhi Ghadah, Al Lababidi Moaz, Al-Najim Werd, Miras Alexander D, Ruban Aruchuna, Glaysher Michael A, Prechtl Christina G, Byrne James P, Teare Julian P, Goldstone Anthony P

Primary Institution: Imperial College London

Hypothesis

In adults with obesity, long-term weight loss through caloric restriction will decrease fasting and/or postprandial plasma LEAP2, which will positively correlate with decreases in weight and improvements in glucose metabolism.

Conclusion

The study found that fasting plasma LEAP2 decreased with weight loss from a low-calorie diet, while the decrease was delayed and attenuated after Endobarrier insertion.

Supporting Evidence

  • Fasting plasma LEAP2 decreased significantly with weight loss over 2 years.
  • LEAP2 levels were positively correlated with BMI and metabolic markers.
  • Postprandial LEAP2 increased after a fixed meal but did not change significantly with weight loss.

Takeaway

When people lose weight by eating less, a hormone called LEAP2 goes down, which helps control hunger. But when a special device is used to help with weight loss, LEAP2 doesn't drop as much.

Methodology

Plasma LEAP2 was measured in a 2-year trial comparing standard medical management with duodenal-jejunal bypass liner insertion in adults with obesity and type 2 diabetes.

Potential Biases

Potential confounding factors include the use of proton pump inhibitors and differences in dietary intake between groups.

Limitations

The study had a limited sample size for postprandial plasma LEAP2 results and did not include a sham procedure for the control group.

Participant Demographics

Participants were adults with obesity (BMI 30-50 kg/m2) and inadequately controlled type 2 diabetes (HbA1c 7.7%-11.1%).

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1210/jendso/bvae214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication